wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47418286-3BB274BA-BDA6-4FD9-9E6F-3FC82042F2D6
Q47418286-3BB274BA-BDA6-4FD9-9E6F-3FC82042F2D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47418286-3BB274BA-BDA6-4FD9-9E6F-3FC82042F2D6
Comparative effectiveness of the biosimilar CT-P13.
P2860
Q47418286-3BB274BA-BDA6-4FD9-9E6F-3FC82042F2D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47418286-3BB274BA-BDA6-4FD9-9E6F-3FC82042F2D6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c51c248ca3cc625cef91a49b3c4f2b60aabd18e1
P2860
Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.